logo
EHP Inc. Launches National Affiliate Expansion Initiative to Accelerate Employer Healthcare Innovation Under Mardy Gould's Leadership

EHP Inc. Launches National Affiliate Expansion Initiative to Accelerate Employer Healthcare Innovation Under Mardy Gould's Leadership

Business Upturn12-06-2025
Jacksonville, FL, June 11, 2025 (GLOBE NEWSWIRE) — EHP Inc., a leading provider of compliant, tax-efficient employee benefit programs, announced the launch of its 2025 National Affiliate Expansion Initiative, a strategic move aimed at scaling its transformative employer-focused healthcare model across the U.S. The initiative is spearheaded by Co-Founder and Managing Partner Mardy Gould, reaffirming the company's commitment to innovation, compliance, and growth through a robust partner ecosystem.
Mardy Gould
This newly launched initiative marks a pivotal step in EHP Inc.'s nationwide growth strategy, offering new opportunities for professionals and non-traditional partners to join the company's thriving affiliate network. With over 10,000 affiliates already active, the expansion initiative will provide additional training, real-time tools, and access to EHP's proprietary AI-powered compliance infrastructure, enabling partners to deliver the company's tax-smart, employee-first benefits model with confidence and scale.
A Timely Expansion Driven by Founder-Led Vision
The launch of the Affiliate Expansion Initiative comes amid increasing demand from mid-sized and large employers seeking effective ways to lower healthcare costs and improve employee engagement without overhauling their existing insurance. EHP Inc.'s structure, based on IRS Sections 125, 105, and 213(d), allows employers to reduce their FICA tax burden by $650 to $750 per employee annually while enhancing preventive healthcare access.
'This expansion initiative reflects our belief that smart growth starts with strong partners,' said Mardy Gould. 'We built EHP Inc. on the principles of compliance, transparency, and impact — and we're inviting professionals across the country to be part of a proven model that actually helps employers solve real problems.'
The Employer's Choice for Modern, Tax-Advantaged Healthcare
EHP Inc. stands out by offering a fully IRS-compliant model that integrates seamlessly with existing payroll systems and insurance plans. The program requires no out-of-pocket costs from employers and offers employees a suite of wellness services, including virtual primary care, care navigation, and personalized advocacy, services that are delivered in addition to any current benefits.
Legal and ERISA-reviewed, the EHP structure helps employers retain talent, improve health outcomes, and achieve cost-efficiency without introducing unnecessary complexity.
What Makes the 2025 Expansion Initiative Newsworthy
The launch of this initiative represents a major milestone for EHP Inc. It includes: Regional Training Sessions: A calendar of in-person and virtual affiliate training sessions scheduled across major U.S. cities beginning July 2025.
A calendar of in-person and virtual affiliate training sessions scheduled across major U.S. cities beginning July 2025. Enhanced Partner Tools: Access to a newly updated Affiliate Portal, with AI-powered proposal generation, real-time commission tracking, and automated compliance updates.
Access to a newly updated Affiliate Portal, with AI-powered proposal generation, real-time commission tracking, and automated compliance updates. Tiered Compensation Model: A refined affiliate earnings structure designed to accelerate success for both new and experienced partners.
A refined affiliate earnings structure designed to accelerate success for both new and experienced partners. Turnkey Onboarding: Streamlined onboarding powered by smart automation, ensuring that affiliates can activate quickly and compliantly.
These enhancements are expected to double the company's affiliate footprint by year's end and strengthen its position as The Employer's Choice in employer-driven healthcare benefits.
AI-Driven Compliance and National Infrastructure
Central to the success of EHP Inc.'s model is its proprietary compliance automation platform, which governs everything from onboarding and documentation to payroll analysis and partner communications. The platform uses AI to maintain IRS and ERISA compliance while minimizing administrative burden for both employers and affiliates.
'Our infrastructure isn't just scalable; it's protective,' said Gould. 'Every piece of our system is designed to safeguard our clients, our partners, and our mission.'
Leadership Continuity Fuels Nationwide Momentum
Unlike many rapidly growing companies, EHP Inc. remains founder-led, with its original leadership team still driving strategic direction. Mardy Gould continues to play an active role in expanding partnerships, shaping program design, and advocating for smarter employer benefits at industry forums nationwide.
'We've never lost sight of why we started EHP,' Gould added. 'Our mission was, and still is, to give employers better choices through compliant, tax-savvy solutions. This affiliate expansion is a natural extension of that promise.'
About EHP Inc.
Headquartered in Jacksonville, Florida, EHP Inc. is a national employer solutions provider offering tax-advantaged, IRS-compliant benefit programs under IRS Sections 125, 105, and 213(d). The company helps businesses lower payroll tax liability and redirect those savings toward meaningful, preventive care for employees. With a strong legal foundation, AI-driven compliance, and a growing network of affiliates, EHP Inc. is redefining how companies manage cost, care, and compliance.
To learn more about the 2025 National Affiliate Expansion Initiative or to become an affiliate, visit www.getehp.com.
EHP The Employer's Choice
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Faith-Based Firm Led by Bob Doll Adds First ETFs
Faith-Based Firm Led by Bob Doll Adds First ETFs

Yahoo

timean hour ago

  • Yahoo

Faith-Based Firm Led by Bob Doll Adds First ETFs

Bob Doll's latest mark on the religious-values firm Crossmark Global Investments is the introduction of two ETFs, the first such products that firm has offered in the wrapper. Last week, the company launched its Crossmark Large Cap Growth and Large Cap Value ETFs, both of which are copies of strategies in separately managed accounts that Doll, the CEO, added to the company when he started there four years ago. The funds invest in Russell 1000 companies, excluding those involved in alcohol, tobacco, abortions, stem-cell research, adult entertainment or cannabis. The corresponding SMAs have beaten their benchmarks and have pulled in new money, reaching a combined total of about $700 million. But, as Doll said he told his company, 'we can be a firm if we don't have ETFs — but if we really want to thrive we need ETFs.' READ ALSO: What Coca-Cola's New Sugar-Cane Coke Means for a Sugar ETF and Why the SEC Keeps Putting Off Diversified Crypto ETFs Spreading the Gospel About two-thirds of Crossmark's assets are in portfolios with religious values screens, Doll said. 'We're very broad-based. Our goal is to avoid products that are designed to maim or kill people,' he told ETF Upside. The firm could eventually have six to eight ETFs in its lineup, he noted. While there are more than 40 US ETFs with Christian or Sharia-compliant investment strategies, financial advisors said there is room for more products: Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Thor Metals Group: Best Overall Gold IRA 'The number of religious-specific ETFs is still rather low, resulting in ETFs that are built for a broader client base,' said Omen Quelvog, founder of Formynder Wealth Management. 'The difficulty there is the number of holdings that could still cause a conflict.' 'Some are solid, but many are too generic and often don't show clearly what's inside them. That lack of clarity doesn't work for values-based families who want more intention behind their investments,' said Daniel Goodman, founder of Good Better Best Financial Planning. 'That's why I often use direct indexing.' Branches and Denominations: Crossmark and others provide a range of strategies to reflect nuances in faith, though it can be difficult to offer something for everyone. 'As a Catholic myself, I appreciate the attempt to create religious ETFs,' said Alvin Carlos, managing partner of District Capital Management. 'But I am skeptical about whether one can truly reflect one's religious beliefs. There are so many angles to consider.' This post first appeared on The Daily Upside. To receive exclusive news and analysis of the rapidly evolving ETF landscape, built for advisors and capital allocators, subscribe to our free ETF Upside newsletter. Sign in to access your portfolio

AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's Tetravalent Shigella Vaccine Candidate
AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's Tetravalent Shigella Vaccine Candidate

Business Wire

time5 hours ago

  • Business Wire

AGC Biologics' Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva's Tetravalent Shigella Vaccine Candidate

SEATTLE & HEIDELBERG, Germany--(BUSINESS WIRE)-- AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply drug substance for an investigational four-valent Shigella bioconjugate vaccine at the CDMO's Heidelberg facility. Valneva exclusively licensed the vaccine candidate from LimmaTech Biologics AG, which previously worked with AGC Biologics to establish GMP-compliant manufacturing and quality control of the vaccine's complex protein-polysaccharide conjugates for first-in-human studies. The objective of the new partnership with Valneva is to establish phase II supply relying on the ability of AGC Biologics' Heidelberg site to guide complex molecules through clinical stages. Valneva and LimmaTech announced the launch of a Phase 2 infant study in April, and a Phase 2b Human Challenge Study (CHIM) in November 2024. Shigellosis is the second leading cause of fatal diarrheal disease worldwide, strongly contributing to pediatric morbidity and mortality. It is estimated that up to 165 million infections are due to Shigella, of which 62.3 million occur in children younger than five years. Developing an effective vaccine to prevent this deadly disease is a public health imperative for many areas of the world. "Our site's unique ability to handle complex molecules and multi-valent assets can help this potentially life-saving program reach its next clinical milestone," said Dieter Kramer, Senior Vice President and General Manager, AGC Biologics Heidelberg. "We appreciate Valneva entrusting our team of experts with this challenge and are honored to contribute to efforts that aim to prevent millions of deadly infections in the future." AGC Biologics runs multiple cGMP microbial fermentation lines at its Heidelberg facility. The site has produced biologics products for 40 years. It offers developers freedom-to-operate strain development, proven experience with different bacterial and yeast systems, proprietary plasmid DNA (pDNA) and messenger RNA (mRNA) platforms, large-scale tanks for late-phase protein refolding, the ability to take on early-phase and fast track projects, and late-phase and commercial expertise. To learn more about the microbial system-based biologics, pDNA and mRNA manufacturing site in Heidelberg, visit For more information on AGC Biologics' global CDMO services across all modalities, go to About AGC Biologics AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, to provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with locations in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. We currently employ more than 2,600 Team Members worldwide. AGC Biologics is a part of AGC Inc.'s Life Science Business. The Life Science Business runs 10+ facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit

Financing a Car? Find Out If This New Tax Deduction Could Lower Your Costs
Financing a Car? Find Out If This New Tax Deduction Could Lower Your Costs

Yahoo

time6 hours ago

  • Yahoo

Financing a Car? Find Out If This New Tax Deduction Could Lower Your Costs

There are several ways to buy a new car, from purchasing one outright with cash to financing it through a car loan. Now, however, a provision in the recently passed One Big Beautiful Bill (OBBB) provides a little tax incentive for anyone thinking of financing a car through 2028. Find Out: Read Next: 'As of 2025, when you buy an automobile for personal, nonbusiness use, not a lease, a loan you borrow for it can be deductible for interest. It hadn't been deductible for a while, so it's a significant change,' according to Alex Black, CMO of EpicVIN. Find out if this tax deduction can make it cheaper for you to finance a new car. What the Provision Says Effective immediately (and retroactively through 2025), for any car purchased between 2025 and 2028, you may deduct interest paid on a loan of a 'qualified vehicle' so long as the vehicle is for personal use. A qualified vehicle, according to the IRS page, 'is a car, minivan, van, SUV, pick-up truck or motorcycle, with a gross vehicle weight rating of less than 14,000 pounds.' This only applies to new vehicles, so used car buyers will have to find other ways to justify their purchases. Learn More: Focus on American Made For lovers of Japanese, German and other overseas carmakers, there won't be as much tax incentive for you. Ruth Calkins, auto expert and general manager at Findbyplate, pointed out that 'The OBBB limits its tax deductions to American assembled new vehicles alone, and does not include a provision for used vehicles, much less those assembled outside America.' While there's a lot of gray area around whether a car has been fully made or assembled in the U.S., you'll be able to get this answer through your car's vehicle identification number (VIN). However, unlike the clean vehicle tax credit that only covers electric vehicles (EVs), the OBBB vehicle loan deduction is more inclusive and accommodating of both internal combustion engine vehicles and EVs, Calkins said. And, since that EV credit is going to be phased out after Sept. 30, 2025, this might be a good way to get a bit of a break. Be Aware of Income Limitations While there is a limit on how much interest you can deduct, 'as long as the vehicle satisfies the eligibility requirements, the vehicle qualifies for the tax deduction,' Calkins said. Apart from the loan origination date, Calkins said, 'another caveat that buyers should take note of before daydreaming about all the things they could do with this tax break come next taxing season, is the income limitation.' Additionally, given that the deduction only extends to individual consumers with a modified adjusted gross income (AGI) of $100,000 or less, and $200,000 for those filing jointly, many people will not qualify for this deduction. Itemizers Only There's one more caveat, Black said. 'You will have to itemize your deductions in order for you to claim it, something not everyone does anymore since the standard deduction went up.' So, if you normally take the standard, this may not help you. What If You Bought a Car This Year Already? If you already took out a loan on an otherwise qualifying vehicle and you're wondering if you're eligible based on purchase date, the key is simple: If you purchased it in 2025, you can still qualify for the deduction. 'However, if you are already in a car loan [from 2024 or earlier], sorry — no discount for you,' Black said. How Much Can You Save? How much you can save will depend on how much you borrow and your interest rate, Black said. However, it is worth noting that the average person taking advantage of this tax break isn't going to spend anywhere close to $10,000 in auto loan interest in a year. According to car website Edmunds, you'd have to take out an auto loan of around $112,000, which is more than double the average price of a new vehicle, to even pay that much in annual interest. Let's say you did take out a $25,000 loan at 7% interest, Black said 'You'll pay roughly $1,750 in interest in year one. If you're in the 22% tax bracket, you might get nearly $400 off your tax bill. Not bad.' Overall Impact on Auto Buyers? Black suggested the tax credit may make more people choose buying over leasing and it can also soften the blow of rising interest rates a bit. 'It won't make a significant impact, though, but it could very well decide for price-conscious buyers.' More From GOBankingRates 7 Things You'll Be Happy You Downsized in Retirement This article originally appeared on Financing a Car? Find Out If This New Tax Deduction Could Lower Your Costs Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store